Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women's and Children's Health's ASPIRIN Trial

S. Jessani, S. Saleem, M. K. Hoffman, S. S. Goudar, R. J. Derman, J. L. Moore, A. Garces, L. Figueroa, N. F. Krebs, J. Okitawutshu, A. Tshefu, C. L. Bose, M. Mwenechanya, E. Chomba, W. A. Carlo, P. K. Das, A. Patel, P. L. Hibberd, F. Esamai, E. A. LiechtyS. Bucher, T. L. Nolen, M. Koso-Thomas, M. Miodovnik, E. M. McClure, R. L. Goldenberg

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women's and Children's Health's ASPIRIN Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science